Gilman Hill Asset Management LLC Has $7.23 Million Stock Holdings in DocuSign, Inc. (NASDAQ:DOCU)

Gilman Hill Asset Management LLC decreased its stake in shares of DocuSign, Inc. (NASDAQ:DOCU) by 2.5% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 80,422 shares of the company’s stock after selling 2,025 shares during the period. DocuSign accounts for approximately 1.3% of Gilman Hill Asset Management LLC’s holdings, making the stock its 22nd biggest holding. Gilman Hill Asset Management LLC’s holdings in DocuSign were worth $7,233,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. bought a new position in DocuSign in the third quarter valued at about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign in the 3rd quarter valued at about $33,000. Modus Advisors LLC bought a new position in shares of DocuSign in the 4th quarter valued at about $36,000. Reston Wealth Management LLC acquired a new stake in shares of DocuSign during the 3rd quarter worth approximately $47,000. Finally, Wilmington Savings Fund Society FSB acquired a new position in DocuSign in the third quarter valued at approximately $51,000. Institutional investors own 77.64% of the company’s stock.

Insiders Place Their Bets

In other news, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $91.26, for a total value of $912,600.00. Following the completion of the transaction, the director now owns 150,253 shares of the company’s stock, valued at $13,712,088.78. This trade represents a 6.24 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Blake Jeffrey Grayson sold 15,588 shares of the company’s stock in a transaction that occurred on Wednesday, December 18th. The shares were sold at an average price of $97.78, for a total value of $1,524,194.64. Following the completion of the sale, the chief financial officer now owns 85,851 shares in the company, valued at $8,394,510.78. This represents a 15.37 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 693,537 shares of company stock worth $66,575,817. Corporate insiders own 1.66% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on DOCU. Jefferies Financial Group lifted their target price on shares of DocuSign from $80.00 to $95.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. JPMorgan Chase & Co. upped their price objective on DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a report on Tuesday, December 3rd. JMP Securities restated a “market outperform” rating and set a $124.00 target price on shares of DocuSign in a report on Tuesday, January 7th. Morgan Stanley boosted their target price on DocuSign from $62.00 to $97.00 and gave the stock an “equal weight” rating in a research report on Friday, December 6th. Finally, Royal Bank of Canada reiterated a “sector perform” rating and issued a $90.00 price target (up from $57.00) on shares of DocuSign in a research report on Friday, December 6th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, DocuSign has an average rating of “Hold” and an average target price of $92.45.

DocuSign Stock Down 1.7 %

DocuSign stock opened at $89.60 on Monday. The stock has a market capitalization of $18.10 billion, a PE ratio of 18.47, a price-to-earnings-growth ratio of 8.17 and a beta of 0.88. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The company has a 50 day moving average of $88.76 and a 200-day moving average of $70.38.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.